One Carbon Metabolism

One Carbon Metabolism is the interconnected folate cycle and methionine cycle biochemical network through which single-carbon units, derived principally from serine and glycine, are transferred, interconverted, and delivered to a wide range of downstream biosynthetic and epigenetic reactions, elevated and reorganized in cancer cells to support the substantial nucleotide synthesis, redox balance, and methylation demands of sustained proliferation. Building on the serine-glycine supply pathway introduced under amino acid metabolism, this topic addresses the full folate and methionine cycle network in greater depth, including its subcellular compartmentalization and its position as a long-established and continuing chemotherapeutic target.

The Folate Cycle and Its Subcellular Compartmentalization

The folate cycle operates as two parallel, functionally coupled sub-cycles located in distinct cellular compartments, an organizational feature of particular relevance to understanding pathway regulation and vulnerability in cancer:

Serine hydroxymethyltransferase (SHMT), existing as distinct cytosolic (SHMT1) and mitochondrial (SHMT2) isoforms, catalyzes the entry reaction transferring serine's third carbon to tetrahydrofolate (THF), generating 5,10-methylene-tetrahydrofolate and glycine; this single-carbon unit is subsequently interconverted among several folate derivatives (10-formyl-THF, 5-methyl-THF) by MTHFD1 (cytosolic) and MTHFD2 (mitochondrial) enzyme complexes, with the mitochondrial and cytosolic pools functioning semi-independently but exchanging one-carbon-loaded folate derivatives and glycine to balance flux between the two compartments according to the cell's specific biosynthetic demands at a given time.

Downstream Outputs of the One-Carbon Pool

The single-carbon units mobilized through the folate cycle are distributed across several essential downstream biosynthetic and regulatory pathways:

1. Purine Ring Synthesis — Two distinct carbon atoms within the purine ring structure are directly contributed by formyl-THF-derived one-carbon units, making folate cycle flux directly rate-limiting for adenine and guanine nucleotide production.
2. Thymidylate Synthesis — 5,10-methylene-THF donates a carbon unit in the conversion of deoxyuridylate to deoxythymidylate, catalyzed by thymidylate synthase, providing the sole de novo route to the thymine nucleotide required specifically for DNA (rather than RNA) synthesis.
3. Methionine Regeneration and the Methionine Cycle — 5-methyl-THF donates its carbon unit to regenerate methionine from homocysteine via methionine synthase, feeding into the methionine cycle in which methionine is subsequently converted to S-adenosylmethionine (SAM), the universal methyl donor for the DNA and histone methylation reactions central to the broader epigenetic regulation discussed throughout cancer cell biology.

Diagram: One-Carbon Unit Distribution Across Downstream Pathways

Historical and Continuing Chemotherapeutic Target

One-carbon metabolism holds particular significance in oncology as the target of the earliest successful class of rationally designed chemotherapeutic agents, the antifolates:

Methotrexate, one of the first effective chemotherapeutic agents developed and still in widespread clinical use, inhibits dihydrofolate reductase (DHFR), the enzyme required to regenerate active tetrahydrofolate from its oxidized dihydrofolate form, depleting the active folate pool and thereby impairing both purine and thymidylate synthesis; pemetrexed, a more recently developed antifolate, inhibits multiple one-carbon pathway enzymes including thymidylate synthase directly, and remains a standard therapy for several solid tumor types, illustrating the sustained clinical relevance of this pathway across nearly the full history of modern cancer chemotherapy.

Elevated Pathway Flux and MTHFD2 as a Cancer-Selective Marker

Beyond the serine synthesis pathway entry point, the mitochondrial folate cycle enzyme MTHFD2 is among the most consistently and highly overexpressed metabolic enzymes across a broad range of human cancer types relative to normal adult tissue, where its expression is largely restricted to embryonic development, making MTHFD2 both a marker of the elevated one-carbon metabolic flux characteristic of cancer cells and a candidate target for newer generation, more selectively cancer-targeted one-carbon pathway inhibitors currently in preclinical and early clinical development.

Experimental Assessment

One-carbon metabolism is assessed using stable isotope tracing with labeled serine to map carbon flux through the cytosolic and mitochondrial folate cycle sub-compartments and into purine, thymidylate, and methionine cycle outputs via mass spectrometry, quantification of intracellular SAM and S-adenosylhomocysteine (SAH) levels as a direct readout of cellular methylation potential, and genetic or pharmacological inhibition of specific pathway enzymes (SHMT1/2, MTHFD1/2, DHFR) to establish functional pathway dependence and evaluate candidate therapeutic targeting strategies.